Navigation Links
St. Jude Appoints New Senior Vice President of Public Relations
Date:8/13/2009

MEMPHIS, Tenn., Aug. 13 /PRNewswire-USNewswire/ -- Mary Lynn Carver has joined St. Jude Children's Research Hospital as senior vice president of public relations. Carver comes to Memphis, Tenn. from London where she was most recently global head of group internal communications at AstraZeneca Pharmaceuticals' world headquarters. In her new role, Carver will oversee communications strategy and the management of public relations activities for St. Jude.

Carver comes to St. Jude with extensive experience in health care communications with a focus on oncology, scientific public relations, public affairs and marketing communications.

"We are delighted that Mary Lynn will bring her global experience and public relations expertise to St. Jude," said Dr. William E. Evans, St. Jude director and CEO. "It is increasingly important that the world knows about the progress being made in our labs and clinics, and Mary Lynn brings strong leadership to our Public Relations team."

Since 1998, Carver has served in several capacities at AstraZeneca, including executive director of communications for their U.S. business in Wilmington, Del., and senior director of oncology public affairs, which included management of the AstraZeneca Health Care Foundation and the National Breast Cancer Awareness Month initiative.

Carver's prior experience also includes marketing communications, public relations and investor relations. She is a graduate of Southern Methodist University in Dallas.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medica
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Novo Nordisk Appoints New Leader of North American Business
3. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
4. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
5. Resonant Medical Appoints New Vice President of Global Sales
6. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
7. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
8. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
9. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
10. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
11. Adlyfe Appoints Roxanne Duan as Vice President of Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...PlusofMichiganhaslaunchedfournew HealthPlusSignatu...s18to64andtheirfamilieswhoarelookingtopurchaseaffo...lusSignature plansareavailableonlineat www.HealthP...althPlusservicearea.Moreinformation,includinghelpw...o1-877-562-0907. ,, "Wearepleasedtoofferanarray...
(Date:11/24/2009)...of inflammatory bowel disease is largely unknown, ...9 Advances in Inflammatory Bowel Diseases, the Cro...al & Research Conference, December 3-6 in Holl...tion for Crohn’s disease. , ... The molecular cause of inflammatory bowel disease...
(Date:11/24/2009)...eholidayseasonoftenbringsfamiliesandfriendstogethe...segrievingthedeathofalovedone.Followingadeath,ever...asoncanbringadditionalchallengestothosewhoaregriev...ngChildren,AdolescentsandTheirFamilies,isavailable...fprintandonlineresourcesavailabletohelpchildrengri...
(Date:11/24/2009)...tCall/--HealthSouthCorporation(NYSE: HLS )todayann...nch2009CreditConferenceinNewYorkonDec.2-3,2009. ,...ywillbespeakingonThursday,Dec.3,2009,at3:40p.m.ET....at http://investor.healthsouth.com byclickingonana...hSouthisthenation,slargestproviderofinpatientrehab...
(Date:11/24/2009)...between high- and low-volume centers, study found ... Do hospitals that conduct the most angioplasties ... Maybe not. , Prior research had suggested that...opening procedures, but a new study involving over...als performing more or less equally. , The stud...
Breaking Medicine News(10 mins):Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
...d uterus and into woman,s body cavity , , ...y may be the first operation of its kind in the Un...pital/Columbia University Medical Center removed a...n of an endoscope through a one-inch incision behi...
...d for 8:00AM EDT, Thursday, ... Sciences, Inc.,(OTC Bulletin Board: DSCI), provid... to release its second quarter 2008 results before...8:00 am EDT,instead of the previously announced 11...
... Inc. (NYSE: HGR ) is pleased to announce that Mo...nger Orthopedic Group, Inc. to "positive",from "st...mily credit,rating at "B2.", "We are pleased with...fficer., Hanger Orthopedic Group, Inc., headquart...
...Harvard School of Public Health, today expressed "...thorities of Dr. Kamiar Alaei, a 2007 Masters of S... Dr. Arash Alaei. The brothers are Iranian physici...e, as their whereabouts are unknown, and there has...
...egree to which people are able to adopt realistic ...hope, have been overlooked in policies to tackle H...Social Research Council (ESRC) argues that hope is...ive. Efforts to control the spread of HIV have bee...
...tive study appearing in the August issue of The J... time, if noseless bicycle saddles would be an eff...alth effects, erectile dysfunction and groin numbn... recreational cyclists to alleviate perineal disco...
Other Medicine News:Health News:New Technique Removes Gallbladder Without External Incisions 2Health News:Derma Sciences Conference Call Advisory 2Health News:Hope: An overlooked tool in the battle against HIV/AIDS 2Health News:No-nose bicycle saddles improve penile sensation and erectile function in bicycling police officers 2
(Date:11/24/2009)...KE,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.a...inistration(FDA)hasacceptedforreviewEisai,sNewDrug...pezilHClextendedrelease)tabletsforthetreatmentofmo...doseformulationcontains23mgofdonepezilHClinanexten...tallowsforgradualreleaseofthedrug.TheNDAisbasedona...
(Date:11/24/2009)....,Nov.24/PRNewswire/--PharmaceuticalInstitute,alea...armaceuticalandbiotechindustry,todayannouncedthela...new HospitalMarketplace e-courseisthenewestadditio...s,acomprehensiveseriesofe-coursesdesignedtofillthe...edgeforcommercialprofessionals. ,, Thenewthreem...
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--CardioGenic...echnologyandproductstargetingtheimmunoassaysegment...("MerckChimie")isprogressingtothenextphaseofthecom...edparamagneticBeads("Beads"). ,, Pertheagreemen...dioGenicssuppliedMerckChimiewithitsproprietarysilv...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Sigma Aldrich 28Nasdaq 3A SIAL 29 Declares Quarterly Dividend 13508 1Really Think Different 54252 1Really Think Different 54252 2Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 1Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 2Introducing All New IEHP Superhero to Battle Childhood Obesity 54248 3
...07 - Australian,biotechnology company Avexa (ASX:A...,s controlled, double blinded phase which,represen...l.,Patients have now progressed into the open-labe...ontinue to receive 800mg,apricitabine twice a day ...ny expects to release results from the 24 week bli...
...e of Science,researchers from the National Instit...meö University in Sweden report an,important ... called,DNA polymerase epsilon plays in replicatin...s even humans. , The study places us one step clos...ity that underlie certain environmental diseases,i...
Other Medicine Technology:Avexa's Apricitabine Clinical Trial Update 2NIEHS Researchers Identify Enzyme Critical in DNA Replication 2NIEHS Researchers Identify Enzyme Critical in DNA Replication 3
... intraocular membranes in vitreoretinal surgery, t...Membraneblue in an air-filled vitreous cavity, the...g the dye. After removal of all excess dye under a...nguished from the underlying, unstained retina aft...
Auroblue
Surgicel Absorbable Hemostat Family
KOWA Refkeratometer KW-2000
Medicine Products: